ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,719Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 623

$448K Total Retail Price of All Prescriptions

Rank: 52 out of 623

207 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

30% of this provider’s 207 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

5% of this provider’s 207 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 7,533 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $66 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
WARFARIN SODIUM 527 505 1 14
FUROSEMIDE 336 316 2 5
TRAMADOL HCL 180 155 3 15
POLYETHYLENE GLYCOL 3350 177 159 4 53
DONEPEZIL HCL 171 158 5 27
JANTOVEN 146 134 6 54
LISINOPRIL 145 140 7 1
METOPROLOL TARTRATE 138 129 8 9
AMLODIPINE BESYLATE 138 123 8 3
SERTRALINE HCL 136 135 10 20
LEVOTHYROXINE SODIUM 128 112 11 4
QUETIAPINE FUMARATE 125 123 12 51
MIRTAZAPINE 119 114 13 31
GABAPENTIN 119 88 13 18
OXYCODONE-ACETAMINOPHEN 116 79 S2 15 42
CITALOPRAM HBR 106 97 16 21
OMEPRAZOLE 104 94 17 7
FENTANYL 102 58 S2 18 76
METFORMIN HCL 96 60 19 6
SIMVASTATIN 95 84 20 2
LOVASTATIN 90 90 21 25
CARVEDILOL 90 78 21 32
NAMENDA 89 89 23 47
ISOSORBIDE MONONITRATE ER 87 76 24 64
METOPROLOL SUCCINATE 87 87 24 13
IPRATROPIUM-ALBUTEROL 86 69 26 91
ALBUTEROL SULFATE 85 77 27 69
TRAZODONE HCL 85 70 27 36
OXYCODONE HCL 80 39 S2 29 30
LANTUS 73 57 30 41
KLOR-CON M20 72 69 31 62
POTASSIUM CHLORIDE 71 61 32 24
GLIPIZIDE 66 53 33 33
HYDROCHLOROTHIAZIDE 66 54 33 8
ALENDRONATE SODIUM 66 66 33 37
PREDNISONE 64 59 36 40
TAMSULOSIN HCL 63 63 37 35
RANITIDINE HCL 61 54 38 23
OXYCONTIN 61 58 S2 38 137
LEVOFLOXACIN 60 48 40 72
DILTIAZEM HCL 60 48 40 257
NYSTATIN 60 51 40 141
ZOLPIDEM TARTRATE 56 42 43 22
PANTOPRAZOLE SODIUM 56 44 43 26
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 51 45 78
ESCITALOPRAM OXALATE 50 50 46 60
LACTULOSE 50 35 46 67
CARBIDOPA-LEVODOPA 50 50 46 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 22, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.